Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|August 6, 2016
Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical propertiesDavid L Sloman, Njamkou Noucti, Michael D Altman, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2016
MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentationAndrew M Haidle, Kaleen K Childers, Anna A Zabierek, et al.
Brain : a Journal of Neurology|October 13, 2006
Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic studyBradley F Boeve, Matt Baker, Dennis W Dickson, et al.
BMC Genomics|January 14, 2010
High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylationDavid O Azorsa, RiLee H Robeson, Danielle Frost, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitorsJason D Katz, Andrew Haidle, Kaleen K Childers, et al.
Brain : a Journal of Neurology|August 23, 2015
Closing the tau loop: the missing tau mutationAllan McCarthy, Roisin Lonergan, Diana A Olszewska, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Colchicine promotes atherosclerotic plaque stability independently of inflammationWeizhen Li, Alexander Lin, Michael Hutton, et al.
Human Molecular Genetics|December 24, 2004
Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator geneNilüfer Ertekin-Taner, James Ronald, Lars Feuk, et al.
Acta Neuropathologica|July 29, 2003
The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathyMarion Hogg, Zoran M Grujic, Matt Baker, et al.
The New England Journal of Medicine|August 3, 2007
Whole-genome analysis of sporadic amyotrophic lateral sclerosisTravis Dunckley, Matthew J Huentelman, David W Craig, et al.
Pageof 8